Phase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect Post author: Post published:May 22, 2026 Post category: Continue ReadingPhase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect
Autologous ARTEMIS® T Cells to Treat Refractory/Relapsed Pediatric Liver Cancer Post author: Post published:May 22, 2026 Post category: Continue ReadingAutologous ARTEMIS® T Cells to Treat Refractory/Relapsed Pediatric Liver Cancer
Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients Post author: Post published:May 22, 2026 Post category: Continue ReadingReduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients
A Phase 1b, Randomized, Blinded, Placebo-Controlled Dose-Ranging Study of GNSC-001 Evaluating Safety, Pharmacodynamics, and Biomarkers in Knee OA Post author: Post published:May 22, 2026 Post category: Continue ReadingA Phase 1b, Randomized, Blinded, Placebo-Controlled Dose-Ranging Study of GNSC-001 Evaluating Safety, Pharmacodynamics, and Biomarkers in Knee OA
A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 Post author: Post published:May 22, 2026 Post category: Continue ReadingA Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1
AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205 Post author: Post published:May 22, 2026 Post category: Continue ReadingAB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205
TACH101: A Potent, First-In-Class KDM4 Inhibitor for Advanced Cancers Post author: Post published:May 22, 2026 Post category: Continue ReadingTACH101: A Potent, First-In-Class KDM4 Inhibitor for Advanced Cancers
Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant Post author: Post published:May 22, 2026 Post category: Continue ReadingSequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant
A Phase I Study of Multiple doses of NSC-Based Oncolytic Virotherapy Administered Intracerebrally to Patients with Recurrent High-Grade Gliomas Post author: Post published:May 22, 2026 Post category: Continue ReadingA Phase I Study of Multiple doses of NSC-Based Oncolytic Virotherapy Administered Intracerebrally to Patients with Recurrent High-Grade Gliomas
Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy Post author: Post published:May 22, 2026 Post category: Continue ReadingPhase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy
